title: Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: a return to control measures.
abstract: Neural stem cells (NSC) have been shown to migrate towards damaged areas, produce trophic factors, and replace lost cells in ways that might be therapeutic for Parkinson's disease (PD). However, there is very little information on the effects of NSC on endogenous cell populations. In the current study, effects of implanted human NSC (hNSC) on endogenous tyrosine hydroxylase-positive cells (TH+ cells) after treatment with 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) were explored in nonhuman primates. After MPTP damage and in PD, the primate brain is characterized by decreased numbers of dopamine neurons in the substantia nigra (SN) and an increase in neurons expressing TH in the caudate nucleus. To determine how implanted NSC might affect these cell populations, 11 St. Kitts African green monkeys were treated with the selective dopaminergic neurotoxin, MPTP. Human NSC were implanted into the left and right caudate nucleus and the right SN of eight of the MPTP-treated monkeys. At either 4 or 7 months after NSC implants, the brains were removed and the size and number of TH+ cells in the target areas were assessed. The results were compared to data obtained from normal untreated control monkeys and to the three unimplanted MPTP-treated monkeys. The majority of hNSC were found bilaterally along the nigrostriatal pathway and in the substantia nigra, while relatively few were found in the caudate. In the presence of NSC, the number and size of caudate TH+ cells returned to non-MPTP-treated control levels. MPTP-induced and hNSC-induced changes in the putamen were less apparent. We conclude that after MPTP treatment in the primate, hNSC prevent the MPTP-induced upregulation of TH+ cells in the caudate and putamen, indicating that hNSC may be beneficial to maintaining a normal striatal environment.
authors.affiliation: Department of Psychiatry, University of Colorado Health Sciences Center, Denver, CO, USA. kimberly.bjugstad@uchsc.edu
authors.forename: Kimberly B
authors.initials: KB
authors.lastname: Bjugstad
authors.forename: D Eugene
authors.initials: DE
authors.lastname: Redmond
authors.forename: Yang D
authors.initials: YD
authors.lastname: Teng
authors.forename: J D
authors.initials: JD
authors.lastname: Elsworth
authors.forename: R H
authors.initials: RH
authors.lastname: Roth
authors.forename: B C
authors.initials: BC
authors.lastname: Blanchard
authors.forename: Evan Y
authors.initials: EY
authors.lastname: Snyder
authors.forename: John R
authors.initials: JR
authors.lastname: Sladek
mesh_terms: D000818:Animals; D016380:Brain Tissue Transplantation; D048429:Cell Size; D002522:Chlorocebus aethiops; D006801:Humans; D020267:MPTP Poisoning / Q000628:therapy*; D008297:Male; D017072:Neostriatum / Q000166:cytology*; D009474:Neurons / Q000166:cytology* / Q000201:enzymology; D033581:Stem Cell Transplantation; D014183:Transplantation, Heterologous; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D014446:Tyrosine 3-Monooxygenase